Research suggests that nearly 30 million Americans will experience an eating disorder in their lifetime. Yet, despite growing awareness, many still have a limited understanding of these conditions ...
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage ...